Perception of pharmacological equivalence of generics or biosimilars in healthcare professionals in Vienna
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Perception of pharmacological equivalence of generics or biosimilars in healthcare professionals in Vienna ; volume:80 ; number:3 ; day:22 ; month:12 ; year:2023 ; pages:355-366 ; date:3.2024
European journal of clinical pharmacology ; 80, Heft 3 (22.12.2023), 355-366, 3.2024
- Creator
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-023-03603-3
- URN
-
urn:nbn:de:101:1-2404240823424.059768329388
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Binder, Lukas
- Zeitlinger, Markus
- SpringerLink (Online service)
Other Objects (12)
Biosimilars – Biosimilars: ja, aber
Biosimilars
Biosimilars : Handbuch
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
Current perspectives on biosimilars
Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer
Biosimilars in hematology and oncology
PANLAR consensus statement on biosimilars
Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis
Biologicals und Biosimilars in der Nephrologie
Biosimilars – Biosimilars: ja, aber
Biosimilars
Biosimilars : Handbuch
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
Current perspectives on biosimilars
Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer
Biosimilars in hematology and oncology
PANLAR consensus statement on biosimilars
Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis
Biologicals und Biosimilars in der Nephrologie
Biosimilars – Biosimilars: ja, aber
Biosimilars
Biosimilars : Handbuch
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
Current perspectives on biosimilars
Clinical equivalence with G-CSF biosimilars: methodologic approach in a (neo)adjuvant setting in non-metastatic breast cancer
Biosimilars in hematology and oncology
PANLAR consensus statement on biosimilars
Equivalence and switching between biosimilars and reference molecules in rheumatoid arthritis: protocol for a systematic review and meta-analysis